Skip to content

Use of Infrared Photomodulation for Hormonal Balance (Joovvin' for Hormonal Health)

Joovvin' for Hormonal Health

Status
Withdrawn
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04245527
Enrollment
0
Registered
2020-01-29
Start date
2020-01-31
Completion date
2020-06-01
Last updated
2026-09-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Estrogen Deficiency, Testosterone Deficiency

Brief summary

8-week pilot study looking at the impact of Joovv's infrared photo modulation product on male and female hormone levels.

Interventions

DEVICEJoovv Infrared Light Device

Joovv is the leading manufacturer of personal, in-home red light therapy devices

Sponsors

ProofPilot
Lead SponsorINDUSTRY
Joovv
CollaboratorUNKNOWN

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE

Intervention model description

Enrolled individuals will receive a Joovv solo for the 8 week study.

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* United States resident

Exclusion criteria

* current Joovv or other photomodulation therapy user * under medical supervision for medically treatable illness * significant travel during study period * use of birth control

Design outcomes

Primary

MeasureTime frameDescription
Testosterone Changebaseline to week 8in males, change from baseline to week 8
change of thyroid-stimulating hormone (TSH)baseline to week 8in females change in estrogen and progesterone from baseline to week 8
Self report general wellnessbaseline to week 8series of questions at baseline and week 8 on general wellness (modified Short Form-36)

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 18, 2026